Wolfson Berg LTD
FDA import alert and refusal historyBerlin, GermanyFEI 3016767530
As of October 26, 2026, Wolfson Berg LTD (Berlin, Germany) is on the red list of FDA Import Alert 45-02 (Foods with illegal or undeclared colors) for viasil mail potency formulae, published by FDA on April 28, 2020, and has no FDA import refusals recorded since October 2016.
Data from FDA public records, last checked . Request a correction
Current status
- Import alerts
- IA 45-02 · red list
- Last import refusal
- None since October 2016
- Last warning letter
- None found
- Last inspection
- None on record
Every FDA record for Wolfson Berg LTD
1 record, newest first. Each line links to the FDA page it came from.
2020
- Import alert listingListed on Import Alert 45-02red listViasil mail potency formulaeSource
Questions about Wolfson Berg LTD
- Is Wolfson Berg LTD on an FDA import alert?
- Yes. As of October 26, 2026, Wolfson Berg LTD is on the red list of FDA Import Alert 45-02, “Foods with illegal or undeclared colors”, for viasil mail potency formulae; FDA published the listing on April 28, 2020.
- Has FDA refused shipments from Wolfson Berg LTD?
- No FDA import refusals for Wolfson Berg LTD appear in FDA's refusal data since October 2016, as of October 26, 2026.
- What is Wolfson Berg LTD's FEI number?
- Wolfson Berg LTD's FDA Establishment Identifier (FEI) is 3016767530.
- Can shipments from Wolfson Berg LTD still enter the U.S.?
- Shipments of viasil mail potency formulae from Wolfson Berg LTD can be detained without physical examination under Import Alert 45-02; FDA releases them only if evidence shows they do not have the listed violation. Importers must consider this listing in their FSVP evaluation (21 CFR 1.505).
Buying from Wolfson Berg LTD?
Watch it and get the FDA record the day it changes. Free for one supplier.
SupplierRadar is not affiliated with the U.S. Food and Drug Administration. Data comes from public FDA records and may contain errors. This is not legal advice; importers remain responsible for their supplier evaluations.